ベンチャーキャピタル投資の世界市場

ベンチャーキャピタル投資の世界市場は2030年までに11兆3,000億米ドルに達する見込み

2024年に1兆6,000億米ドルと推定されるベンチャーキャピタル投資の世界市場は、2024年から2030年にかけてCAGR 37.8%で成長し、2030年には11兆3,000億米ドルに達すると予測されます。本レポートで分析したセグメントのひとつである米国ソフトウェアセクターは、CAGR 40.9%を記録し、分析期間終了時には5兆2,000億米ドルに達すると予想されます。医薬品・バイオテクノロジー分野の成長率は、分析期間のCAGRで39.8％と推定されます。

米国市場は推定4,485億米ドル、中国はCAGR49.0％で成長予測

米国のベンチャーキャピタル投資市場は、2024年には4,485億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを49.0%として、2030年までに予測市場規模3兆米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ30.3%と34.2%と予測されています。欧州では、ドイツがCAGR約32.1%で成長すると予測されています。

世界のベンチャーキャピタル投資市場- 主要動向と促進要因のまとめ

ベンチャーキャピタルはなぜスタートアップのエコシステムで重要な役割を果たすのか？

ベンチャーキャピタル（VC）投資とは、高いイノベーションの可能性を持ちながら、従来の資金調達へのアクセスが限られているアーリーステージおよびグロースステージの企業への資本配分のことを指します。これらの投資は通常、株式と引き換えに行われ、拡張性、破壊的技術、または強力な市場差別化を提供する新興企業に焦点を当てています。ベンチャーキャピタルは、事業開拓、人材獲得、製品拡大、市場参入を支援し、ソフトウェア、バイオテクノロジー、クリーンエネルギー、フィンテックなどの分野における新興企業の成長に欠かせない存在となっています。

ベンチャーキャピタルはまた、戦略的ガイダンス、経営支援、業界とのコネクションを提供し、金融資本だけにとどまらないです。このハンズオンの関与は、ビジネスモデルの形成、実行リスクの軽減、投資先企業の後期段階での資金調達や買収の準備に役立ちます。ベンチャー・キャピタルの影響力は、アクセラレーター・プログラム、大学のスピンアウト、高成長インキュベーターを中心としたエコシステムが発達しているハイテク主導地域で特に顕著です。時間の経過とともに、ベンチャーキャピタル投資は、ニッチな資金調達方法から、先進国市場と新興国市場の双方で関連性が高まる、世界的に制度化された資産クラスへと進化してきました。

現在の環境において、ディール・フローと投資ステージはどのように進化しているか？

ベンチャーキャピタルの資金調達パターンはより細分化され、アーリーステージ案件はイノベーションリスクに重点を置き、レイトステージ案件は市場牽引力と収益拡張性に重点を置いています。シード・ラウンドとシリーズAラウンドでは、特にスタートアップの活動が成熟しつつある地域において、エンジェル・ネットワーク、コーポレート・ベンチャー部門、マイクロVCからの参加が増加しています。シリーズB以降のラウンドは、ユーザーベースの成長、粗利益率、黒字化への道筋といった指標を優先する大手VCやグロースエクイティ投資家が中心となっています。

ディールサイズは、ディープテック、ヘルステック、気候変動テクノロジーなどのセクターの資本集約度を反映して、過去10年間で大幅に拡大しています。小規模案件の数は依然として多いが、特にAI、デジタル・インフラ、エンタープライズ・ソフトウェアの企業では、メガ・ラウンドが頻繁に行われるようになっています。しかし、市場の調整と金利情勢の変化により、VCはより選択的なアプローチを採用し、持続可能な成長とキャッシュ効率に重点を置くようになっています。このシフトにより、資金調達のスピードは遅くなっているが、すべての投資ステージで精査とデューデリジェンスが強化されています。

VCの投資戦略を再構築している地域やセクターの動向は？

地理的には、シリコンバレー、ニューヨーク、ボストンが依然として主要拠点であり、北米が引き続きベンチャーキャピタル展開の最大シェアを占めています。しかし、アジアと欧州では、ベンガルール、シンガポール、ベルリン、ロンドンなどの都市が注目を集め、大幅な成長を遂げています。ラテンアメリカとアフリカでは、インターネットの普及とデジタル決済の導入が進み、消費者向けフィンテック、ロジスティクス、教育プラットフォームへの投資家の関心が高まっています。

セクター別では、人工知能、サイバーセキュリティ、ヘルス・テクノロジー、グリーン・エネルギーがVCの持続的な関心を集めています。これらの分野の新興企業は、技術的破壊や規制の変革に沿った長期的な構造的成長機会を提供しています。気候変動テクノロジーと持続可能な農業は、環境影響に対する政策支援と投資家の重視に後押しされ、新たな注目分野となっています。同時に、SaaS（Software-as-a-Service）は、サブスクリプションベースの収益モデルと資本の負担が軽いスケーリングの可能性から、引き続き好まれる分野です。こうしたセクター間のシフトは、投資家がより広範に、ミッション主導のイノベーションとインパクトの大きいテクノロジーに軸足を移していることを反映しています。

ベンチャーキャピタル市場の成長と成熟を促す要因とは？

ベンチャーキャピタル投資市場の成長は、イノベーション・サイクル、資本市場の流動性、機関の多様化に関連するいくつかの要因によって牽引されています。年金基金、政府系ファンド、企業投資家の参加が増加し、ベンチャーキャピタル企業の資本基盤が拡大しています。セカンダリー、ファンド・オブ・ファンズ、共同投資モデルの台頭は、ポートフォリオの柔軟性と流動性の選択肢を向上させています。インキュベーター、大学、政策的インセンティブに支えられた新興企業のエコシステムは、地域間で一貫した投資可能な企業のパイプラインを生み出しています。特にAI、フィンテック、持続可能性に関連したビジネスモデルなど、各業界におけるデジタルトランスフォーメーションが、ベンチャー企業展開の新たな領域を開拓しています。さらに、インパクト投資や長期資本戦略への意欲の高まりは、世界の経済変革、技術進歩、起業家精神の成長の推進力としてのベンチャーキャピタルの役割を強化しています。

セグメント

セクター（ソフトウェアセクター、製薬＆バイオテクノロジーセクター、メディア＆エンターテインメントセクター、医療機器＆装置セクター、その他セクター）、タイプ（初回ベンチャー資金調達、フォローオンベンチャー資金調達）、バリエーション（機関投資家、コーポレートベンチャーキャピタル、プライベートエクイティファーム、エンジェル投資家、その他バリエーション）

調査対象企業の例

• 5Y Capital
• Accel
• Andreessen Horowitz（a16z）
• Antler
• Atomico
• Bessemer Venture Partners
• Founders Fund
• General Catalyst
• Greycroft
• Greylock Partners
• Index Ventures
• Lightspeed Venture Partners
• New Enterprise Associates（NEA）
• Qiming Venture Partners
• Sapphire Ventures
• Sequoia Capital
• SOSV
• Techstars
• Tiger Global Management
• Y Combinator

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Venture Capital Investment Market to Reach US$11.3 Trillion by 2030

The global market for Venture Capital Investment estimated at US$1.6 Trillion in the year 2024, is expected to reach US$11.3 Trillion by 2030, growing at a CAGR of 37.8% over the analysis period 2024-2030. Software Sector, one of the segments analyzed in the report, is expected to record a 40.9% CAGR and reach US$5.2 Trillion by the end of the analysis period. Growth in the Pharma & Biotech Sector segment is estimated at 39.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$448.5 Billion While China is Forecast to Grow at 49.0% CAGR

The Venture Capital Investment market in the U.S. is estimated at US$448.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.0 Trillion by the year 2030 trailing a CAGR of 49.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 30.3% and 34.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 32.1% CAGR.

Global Venture Capital Investment Market - Key Trends & Drivers Summarized

Why Does Venture Capital Play a Pivotal Role in Startup Ecosystems?

Venture capital (VC) investment refers to the allocation of capital to early-stage and growth-stage companies with high innovation potential but limited access to traditional financing. These investments typically come in exchange for equity and are focused on startups that offer scalability, disruptive technology, or strong market differentiation. Venture capital supports business development, talent acquisition, product expansion, and market entry, making it a critical enabler of startup growth in sectors such as software, biotechnology, clean energy, and fintech.

VC firms also provide strategic guidance, operational support, and industry connections that extend beyond financial capital. This hands-on involvement helps shape business models, reduce execution risk, and prepare portfolio companies for later-stage funding or acquisition. The influence of venture capital is especially visible in tech-driven regions where ecosystems have developed around accelerator programs, university spinouts, and high-growth incubators. Over time, VC investment has evolved from a niche funding method to a globally institutionalized asset class with growing relevance in both developed and emerging markets.

How Are Deal Flows and Investment Stages Evolving in the Current Environment?

Venture capital funding patterns have become more segmented, with early-stage deals focused on innovation risk and later-stage deals emphasizing market traction and revenue scalability. Seed and Series A rounds are seeing increased participation from angel networks, corporate venture arms, and micro-VCs, especially in regions with maturing startup activity. Series B and later rounds are dominated by large VC firms and growth equity investors who prioritize metrics such as user base growth, gross margins, and path to profitability.

Deal sizes have grown significantly over the past decade, reflecting the capital intensity of sectors like deep tech, health tech, and climate technology. While the number of smaller deals remains substantial, mega-rounds have become more frequent, especially for companies in AI, digital infrastructure, and enterprise software. However, market corrections and changing interest rate conditions are causing VCs to adopt a more selective approach, focusing on sustainable growth and cash efficiency. This shift has slowed funding velocity but increased scrutiny and due diligence across all investment stages.

What Regional and Sectoral Trends Are Reshaping VC Investment Strategies?

Geographically, North America continues to account for the largest share of venture capital deployment, with Silicon Valley, New York, and Boston remaining major hubs. However, Asia and Europe have seen substantial growth, with cities like Bengaluru, Singapore, Berlin, and London gaining prominence. In Latin America and Africa, growing internet penetration and digital payment adoption are fueling investor interest in consumer fintech, logistics, and education platforms.

Sector-wise, artificial intelligence, cybersecurity, health technology, and green energy are attracting sustained VC interest. Startups in these domains offer long-term structural growth opportunities aligned with technological disruption and regulatory transformation. Climate-tech and sustainable agriculture are emerging focus areas, driven by policy support and investor emphasis on environmental impact. At the same time, software-as-a-service (SaaS) continues to be a preferred segment for its subscription-based revenue model and capital-light scaling potential. These sectoral shifts reflect a broader investor pivot toward mission-driven innovation and high-impact technologies.

What Factors Are Driving Growth and Maturity in the Venture Capital Market?

Growth in the venture capital investment market is driven by several factors related to innovation cycles, capital market liquidity, and institutional diversification. Increased participation from pension funds, sovereign wealth funds, and corporate investors is expanding the capital base for VC firms. The rise of secondaries, fund-of-funds, and co-investment models is improving portfolio flexibility and liquidity options. Startup ecosystems supported by incubators, universities, and policy incentives are generating a consistent pipeline of investable companies across regions. Digital transformation across industries is unlocking new areas for venture deployment, particularly in AI, fintech, and sustainability-linked business models. Additionally, growing appetite for impact investing and long-duration capital strategies is reinforcing venture capital’s role as a driver of economic transformation, technological advancement, and entrepreneurial growth worldwide.

SCOPE OF STUDY:

The report analyzes the Venture Capital Investment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sector (Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector, Other Sectors); Type (First-Time Venture Funding, Follow-On Venture Funding); Variant (Institutional Investors, Corporate Venture Capital, Private Equity Firms, Angel Investors, Other Variants)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• 5Y Capital
• Accel
• Andreessen Horowitz (a16z)
• Antler
• Atomico
• Bessemer Venture Partners
• Founders Fund
• General Catalyst
• Greycroft
• Greylock Partners
• Index Ventures
• Lightspeed Venture Partners
• New Enterprise Associates (NEA)
• Qiming Venture Partners
• Sapphire Ventures
• Sequoia Capital
• SOSV
• Techstars
• Tiger Global Management
• Y Combinator

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Venture Capital Investment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Surge in Early-Stage Startup Formation Across Tech-Enabled Sectors Continues to Drive Global Venture Capital Investment Activity
  • Expansion of Digital Infrastructure and SaaS Business Models Fuels Investor Interest in Scalable, High-Margin Startups
  • Rapid Growth of Green Technologies and Sustainability Startups Strengthens the Business Case for Thematic Venture Capital Allocation
  • Rising Appetite for High-Risk, High-Return Alternatives Among Institutional Investors Boosts Venture Capital Fundraising Momentum
  • Proliferation of Regional Innovation Clusters and Startup Ecosystems Broadens Geographic Diversification in VC Portfolios
  • Emergence of Specialized Micro-VC and Sector-Focused Funds Drives Capital Deployment Into Niche High-Growth Markets
  • Growing Role of Government-Backed Incubators and Public-Private Innovation Funds Expands Seed-Stage Investment Activity
  • Expansion of Exit Opportunities via SPACs, IPOs, and Secondary Markets Strengthens Return Outlook for VC Firms
  • Shift Toward Impact-Driven and ESG-Compliant Portfolios Spurs Interest in Inclusive and Responsible Startup Ventures
  • Increased Availability of Alternative Data and AI Tools Enhances Due Diligence Efficiency and Accelerates VC Decision-Making
  • Globalization of Startup Funding and Cross-Border Co-Investment Strategies Expands the Addressable Market for VC Firms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Venture Capital Investment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Venture Capital Investment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Venture Capital Investment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Venture Capital Investment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Software Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Software Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Software Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pharma & Biotech Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Pharma & Biotech Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Media & Entertainment Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Media & Entertainment Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Media & Entertainment Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Medical Devices & Equipment Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Medical Devices & Equipment Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Medical Devices & Equipment Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Sectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Sectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Sectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Private Equity Firms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Private Equity Firms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Private Equity Firms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Angel Investors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Angel Investors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Angel Investors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Variants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Variants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other Variants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Institutional Investors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Institutional Investors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Institutional Investors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Corporate Venture Capital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Corporate Venture Capital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Corporate Venture Capital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for First-Time Venture Funding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for First-Time Venture Funding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for First-Time Venture Funding by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Follow-On Venture Funding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Follow-On Venture Funding by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Follow-On Venture Funding by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• JAPAN
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• CHINA
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• EUROPE
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Venture Capital Investment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Venture Capital Investment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Venture Capital Investment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• FRANCE
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• GERMANY
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Venture Capital Investment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Venture Capital Investment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Venture Capital Investment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• INDIA
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Venture Capital Investment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Venture Capital Investment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Venture Capital Investment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Venture Capital Investment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Venture Capital Investment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Venture Capital Investment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030
• AFRICA
  • Venture Capital Investment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Venture Capital Investment by Sector - Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Venture Capital Investment by Sector - Percentage Breakdown of Value Sales for Software Sector, Pharma & Biotech Sector, Media & Entertainment Sector, Medical Devices & Equipment Sector and Other Sectors for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Venture Capital Investment by Variant - Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Venture Capital Investment by Variant - Percentage Breakdown of Value Sales for Private Equity Firms, Angel Investors, Other Variants, Institutional Investors and Corporate Venture Capital for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Venture Capital Investment by Type - First-Time Venture Funding and Follow-On Venture Funding Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Venture Capital Investment by Type - Percentage Breakdown of Value Sales for First-Time Venture Funding and Follow-On Venture Funding for the Years 2014, 2025 & 2030

IV. COMPETITION